St. Gallen International Breast Cancer 2019 Award Winner Professor Monica Morrow from the Memorial Sloan Kettering Cancer Center, New York, and member of the St. Gallen 2019 international breast cancer consensus panel encourages you to attend this important conference, which will focus on early breast cancer (EBC). St. Gallen Oncology Conferences is proud to welcome the American Society of Clinical Oncology (ASCO) as our newest cooperating partner. This year’s conference main-topic is "Estimating the Magnitude of Clinical Benefit"

Experts of virtually all major cooperative groups and centres world-wide actively engaged in basic and clinical research as well as in clinical management of breast cancer will present their latest data, critically reviewed by leading specialists in the field. At this year’s conference for the second time an outstanding clinician will be honoured with the Umberto Veronesi Memorial Award.

The treatment of EBC is complex and represents a huge responsibility for oncologists. Indeed the aim of this treatment is to cure the patient.

For you as attending journalists (free media registration), the conference is a unique opportunity to meet with the most skilled experts in the field of EBC and to review with them the last two years as well as the future of the diagnosis and treatment of EBC. The organizers of the conference will take every effort to bring you together with your requested interview partner.

According to Professor Monica Morrow, the BCC has always tried to provide the oncologists with tools to personalize the treatment of their patients as best as possible. So the conference essentially helps to interpret the results of the literature, of randomized clinical trials. This is clearly a unique opportunity to meet with colleagues and to discuss with them the results of these trials and to put them into perspective.

As a highlight of the BCC the Saturday morning consensus meeting has always a great demand and every seat in the main conference hall is taken. At the meeting end the delegates come up with a broad consensus on how best to diagnose, treat and advise patients. This consensus will then be published a couple of weeks after the BCC in the Annals of Oncology. The consensus of the BCC 2017 has found a broad audience as will the new consensus in early summer 2019.